#BEGIN_DRUGCARD DB02965

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C5H15N4O6PS

# Chemical_IUPAC_Name:
(2S)-2-amino-5-{[(S)-amino(sulfoamino)phosphoryl]amino}pentanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Ndelta-(N'-Sulphodiaminophosphinyl)-L-Ornithine

# HET_ID:
PSQ

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C5H15N4O6PS/c6-4(5(10)11)2-1-3-8-16(7,12)9-17(13,14)15/h4H,1-3,6H2,(H,10,11)(H,13,14,15)(H4,7,8,9,12)/t4-,16-/m0/s1

# InChI_Key:
InChIKey=MDGVOXPIIICZEK-LQMFNZFOSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2965

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
290.235

# Molecular_Weight_Mono:
290.044991434

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1DUV

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.8

# Predicted_LogS:
-1.7

# Predicted_Water_Solubility:
5.55e+00 g/l

# Primary_Accession_No:
DB02965

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936540

# PubChem_Substance_ID:
46508926

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02674

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
N[C@@H](CCCN[P@](N)(=O)NS(O)(=O)=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:42 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm (Probable)

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
J02842

# Drug_Target_1_GenBank_ID_Protein:
145344

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
argI

# Drug_Target_1_Gene_Sequence:
>1002 bp
TCCGGGTTTTATCATAAGCATTTCCTGAAATTACTCGATTTCACGCCAGCTGAACTCAAC
AGCCTGCTGCAGTTAGCCGCGAAGCTGAAAGCCGATAAGAAAAGCGGTAAAGAAGAAGCC
AAACTCACTGGTAAAAACATCGCGCTCATCTTCGAAAAAGACTCGACTCGTACCCGATGC
TCTTTCGAAGTTGCCGCATATGACCAGGGTGCTCGCGTTACTTATCTCGGCCCAAGCGGC
AGCCAGATTGGTCATAAAGAGTCGATTAAAGACACTGCCCGCGTGCTTGGTCGCATGTAT
GACGGTATTCAGTATCGCGGCTATGGTCAGGAGATTGTCGAAACACTGGCGGAATACGCT
AGCGTGCCGGTATGGAATGGCCTGACCAATGAGTTCCATCCCACGCAGCTGCTGGCGGAT
CTTCTCACCATGCAGGAGCATTTGCCCGGCAAAGCGTTCAACGAAATGACGCTGGTCTAT
GCAGGTGACGCGCGTAACAACATGGGCAATTCGATGCTCGAAGCTGCGGCGCTTACCGGT
CTGGATTTGCGTCTGGTCGCGCCACAAGCGTGCTGGCCGGAAGCTGCGCTGGTTACGGAA
TGCCGCGCCCTGGCACAGCAAAATGGTGGGAATATTACGCTGACTGAAGATGTCGCGAAG
GGAGTTGAAGGTGCTGACTTTATCTATACCGATGTGTGGGTGTCGATGGGGGAAGCAAAA
GAGAAATGGGCGGAACGGATTGCATTGCTGCGTGAATATCAGGTGAACAGCAAGATGATG
CAGTTGACCGGTAACCCGGAGGTCAAATTCCTCCACTGCCTGCCCGCGTTTCATGACGAC
CAAACGACGCTTGGCAAGAAAATGGCGGAAGAATTTGGCCTACATGGCGGTATGGAAGTC
ACTGATGAGGTCTTCGAATCTGCCGCCAGCATTGTTTTTGATCAGGCGGAAAACCGTATG
CATACTATCAAAGCGGTGATGGTCGCGACGCTCAGTAAATAA

# Drug_Target_1_General_Function:
Amino acid transport and metabolism

# Drug_Target_1_General_References:
3072022	Kuo LC, Miller AW, Lee S, Kozuma C: Site-directed mutagenesis of Escherichia coli ornithine transcarbamoylase: role of arginine-57 in substrate binding and catalysis. Biochemistry. 1988 Nov 29;27(24):8823-32.
6369246	Bencini DA, Houghton JE, Hoover TA, Foltermann KF, Wild JR, O'Donovan GA: The DNA sequence of argI from Escherichia coli K12. Nucleic Acids Res. 1983 Dec 10;11(23):8509-18.
7610040	Burland V, Plunkett G 3rd, Sofia HJ, Daniels DL, Blattner FR: Analysis of the Escherichia coli genome VI: DNA sequence of the region from 92.8 through 100 minutes. Nucleic Acids Res. 1995 Jun 25;23(12):2105-19.
9253409	Jin L, Seaton BA, Head JF: Crystal structure at 2.8 A resolution of anabolic ornithine transcarbamylase from Escherichia coli. Nat Struct Biol. 1997 Aug;4(8):622-5.
9275160	Ha Y, McCann MT, Tuchman M, Allewell NM: Substrate-induced conformational change in a trimeric ornithine transcarbamoylase. Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9550-5.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3415

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
36908

# Drug_Target_1_Name:
Ornithine carbamoyltransferase chain I

# Drug_Target_1_Number_of_Residues:
334

# Drug_Target_1_PDB_ID:
1DUV

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00185	OTCace
PF02729	OTCace_N

# Drug_Target_1_Protein_Sequence:
>Ornithine carbamoyltransferase chain I
MSGFYHKHFLKLLDFTPAELNSLLQLAAKLKADKKSGKEEAKLTGKNIALIFEKDSTRTR
CSFEVAAYDQGARVTYLGPSGSQIGHKESIKDTARVLGRMYDGIQYRGYGQEIVETLAEY
ASVPVWNGLTNEFHPTQLLADLLTMQEHLPGKAFNEMTLVYAGDARNNMGNSMLEAAALT
GLDLRLVAPQACWPEAALVTECRALAQQNGGNITLTEDVAKGVEGADFIYTDVWVSMGEA
KEKWAERIALLREYQVNSKMMQLTGNPEVKFLHCLPAFHDDQTTLGKKMAEEFGLHGGME
VTDEVFESAASIVFDQAENRMHTIKAVMVATLSK

# Drug_Target_1_Reaction:
carbamoyl phosphate + L-ornithine = phosphate + L-citrulline

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Carbamoyl phosphate + L-ornithine = phosphate + L-citrulline

# Drug_Target_1_SwissProt_ID:
P04391

# Drug_Target_1_SwissProt_Name:
OTC1_ECOLI

# Drug_Target_1_Synonyms:
EC 2.1.3.3
OTCase-1

# Drug_Target_1_Theoretical_pI:
5.43

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02965
